Maxcyte (MXCT) Intangibles (2025 - 2026)
Maxcyte (MXCT) reported Intangibles of $783000.0 for Q1 2026, up 11.38% year-over-year from $703000.0 in Q1 2025, and up 20.46% on a QoQ basis from $650000.0 in Q4 2025.
Maxcyte (MXCT) has 2 years of Intangibles data on file, last reported at $783000.0 in Q1 2026.
- Quarterly Intangibles rose 11.38% year-over-year to $783000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $783000.0 (up 11.38% YoY) and the FY2025 annual result came in at $650000.0, changed N/A from the prior year.
- Intangibles rose to $783000.0 in Q1 2026 per MXCT's latest filing, from $650000.0 in the prior quarter.
- Across five years, Intangibles topped out at $783000.0 in Q1 2026 and bottomed at $638000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.88 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.52 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.34 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 7.06 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.23 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.14 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.91 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.62 Bn |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn | 783,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 783,000.00 |
| Dec 31, 2025 | 650,000.00 |
| Sep 30, 2025 | 667,000.00 |
| Jun 30, 2025 | 638,000.00 |
| Mar 31, 2025 | 703,000.00 |